The Promise of GLP-1 Drugs: More Than Just Diabetes Management When GLP-1 (Glucagon-Like Peptide-1) receptor agonists first hit the market, they were hailed as a breakthrough in type 2 diabetes
If you have an autoimmune disease, specifically a rheumatologic disease affecting the joints, muscles, bones, and connective tissues, then your mobility can decrease significantly, Lakkis explains
Nikolis A, Enright KM, Fabi SG, et al
And excited to have her here today to kind of talk about that, what shes using it for, and some of the kind of exciting results that shes seen and that Ive seen, you know, after working with some of her clients and such
This is your body adjusting to GLP-1 receptor activation in the gut